/PRNewswire/ Flamingo Therapeutics ("Flamingo") today announced its participation in the following upcoming investor and industry conferences: 23rd Annual.
Acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS)-;two related blood diseases that disproportionally strike older adults-;are notoriously difficult to treat and associated with high relapse rates.
/PRNewswire/ Acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) two related blood diseases that disproportionally strike older adults are.
<p>Acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS)—two related blood diseases that disproportionally strike older adults—are notoriously difficult to treat and associated with high relapse rates. Although new therapies have improved survival, treatment options remain limited, and the prognosis for the 50% of people who experience disease relapse remains poor.</p>